CCS
EMN icon

Concentric Capital Strategies’s Eastman Chemical EMN Stock Holding History

Concentric Capital Strategies’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-59,000
Closed -$5.91M – 318
2024
Q1 		$5.91M Buy
+59,000
New +$5.19M 0.33% 74

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Concentric Capital Strategies's EMN Position: Q4 2023 in Review

Concentric Capital Strategies sold out of Eastman Chemical (EMN) in Q4 2023, closing a stake of 18,271 shares — an estimated $1.4M sold.

Concentric Capital Strategies first reported a position in EMN in Q1 2023 and held it in 2 quarters. The position peaked at $2.68M in Q1 2023. 712 funds tracked by Wall St. Rank hold EMN as of Q4 2023.

  • Concentric Capital Strategies reported no remaining Eastman Chemical position as of Q4 2023 after selling out during the quarter.
  • Concentric Capital Strategies sold 18,271 Eastman Chemical shares in Q4 2023, an estimated $1.4M.
  • Concentric Capital Strategies first reported a position in Eastman Chemical in Q1 2023 and held it in 2 quarters.
  • Concentric Capital Strategies's Eastman Chemical position peaked at $2.68M in Q1 2023.
  • 712 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2023.

Based on Concentric Capital Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.